Gladys C. Completo

Affiliations: 
2001-2008 University of Alberta, Edmonton, Alberta, Canada 
Google:
"Gladys Completo"
Mean distance: 9.84
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Castrosanto MA, Alvarez MR, Salamanez KC, et al. (2021) Barnyard grass [Echinochloa crus-galli (L.) Beauv] leaves extract against tomato pests. Journal of the Science of Food and Agriculture
Ortiz CLD, Completo GC, Nacario RC, et al. (2019) Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies. Scientific Reports. 9: 17096
Du L, Jung ME, Damoiseaux R, et al. (2013) A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1653-60
Cui L, Kitov PI, Completo GC, et al. (2011) Supramolecular complexing of membane Siglec CD22 mediated by a polyvalent heterobifunctional ligand that templates on IgM. Bioconjugate Chemistry. 22: 546-50
Abdu-Allah HH, Watanabe K, Completo GC, et al. (2011) CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold. Bioorganic & Medicinal Chemistry. 19: 1966-71
Chen WC, Completo GC, Sigal DS. (2011) In vivo targeting of B-cell lymphoma with glycan ligands of CD22 (Blood (2010) 115, 23 (4778-4786)) Blood. 117: 5551
Szczepina MG, Zheng RB, Completo GC, et al. (2010) STD-NMR studies of two acceptor substrates of GlfT2, a galactofuranosyltransferase from Mycobacterium tuberculosis: epitope mapping studies. Bioorganic & Medicinal Chemistry. 18: 5123-8
Chen WC, Completo GC, Sigal DS, et al. (2010) In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood. 115: 4778-86
Duong BH, Tian H, Ota T, et al. (2010) Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. The Journal of Experimental Medicine. 207: 173-87
Duong BH, Tian H, Ota T, et al. (2010) Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo (Journal of Experimental Medicine (2010), 207, 1, (173-177)) Journal of Experimental Medicine. 207
See more...